NEW YORK (GenomeWeb News) – The Parkinson's Institute will use Arrayit's microarray platform to search for Parkinson's-related biomarkers in a research collaboration, the company said today.
The study involves collecting samples from well-characterized Parkinson's patients using Arrayit's H25K microarray and PlasmaScan80, with antibodies provided by BioSystems International.
The H25K prints the entire human genome, enabling researchers to study it and test blood samples to determine which genes may be manifesting a particular disease, said Arrayit. Using the PlasmaScan monoclonal antibodies with the H25K makes it possible to find and identify novel biomarkers in the human plasma proteome, the firm said.